Karl D'Silva to Cetuximab
This is a "connection" page, showing publications Karl D'Silva has written about Cetuximab.
Connection Strength
0.018
-
Krishnan G, D'Silva K, Al-Janadi A. Cetuximab-related tumor lysis syndrome in metastatic colon carcinoma. J Clin Oncol. 2008 May 10; 26(14):2406-8.
Score: 0.018